Want to see NL:PHIA full AI Analyst Report?
PHIA Stock Chart & Stats
€25.35
€0.01(0.04%)
At close: 4:00 PM EST
€25.35
€0.01(0.04%)
Day’s Range― - ―
52-Week Range€19.98 - €27.70
Previous CloseN/A
Volume1.64M
Average Volume (3M)1.33M
Market Cap
€23.22B
Enterprise Value€28.01B
Total Cash (Recent Filing)€2.59B
Total Debt (Recent Filing)€8.10B
Price to Earnings (P/E)23.4
Beta0.97
Next Earnings
Jul 28, 2026EPS Estimate
0.35Next Dividend Ex-DateN/A
Dividend Yield3.73%
Share Statistics
EPS (TTM)1.02
Shares Outstanding982,884,770
10 Day Avg. Volume1,198,930
30 Day Avg. Volume1,333,770
Financial Highlights & Ratios
PEG Ratio-0.11
Price to Book (P/B)2.01
Price to Sales (P/S)1.24
P/FCF Ratio24.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€27.00Price Target Upside6.51% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)1.54
Revenue Forecast (FY)€17.90B
Bulls Say, Bears Say
Bulls Say
Analyst Confidence And Risk ProfileAnalyst's recommendation tied to a strong exit rate boosts confidence in the medium-term outlook and reduces perceived downside risk for the stock.
Operating Profit And ProductivityOperating profit exceeded expectations due to operating leverage and productivity measures, indicating the company can lift profitability despite external pressures.
Sales And Order IntakeGroup sales and order intake surpassed expectations, led by stronger performance in personal health and connected care, supporting revenue momentum and investor confidence.
Bears Say
Guidance Versus ConsensusNear-term guidance implies a notable downgrade compared with consensus estimates, which limits upside potential for the stock.
Precision Diagnostics WeaknessSoft performance in precision diagnostics remains a lingering weak spot that could constrain overall growth until the business recovers.
Regulatory Uncertainty In CPAP MarketUnresolved questions around the Consent Decree and a return to the US CPAP market sustain regulatory uncertainty and could delay recovery in related revenue streams.
PHIA FAQ
What was Koninklijke Philips N.V.’s price range in the past 12 months?
Koninklijke Philips N.V. lowest stock price was €19.98 and its highest was €27.70 in the past 12 months.
What is Koninklijke Philips N.V.’s market cap?
Koninklijke Philips N.V.’s market cap is €23.22B.
When is Koninklijke Philips N.V.’s upcoming earnings report date?
Koninklijke Philips N.V.’s upcoming earnings report date is Jul 28, 2026 which is in 27 days.
How were Koninklijke Philips N.V.’s earnings last quarter?
Koninklijke Philips N.V. released its earnings results on May 06, 2026. The company reported €0.23 earnings per share for the quarter, beating the consensus estimate of €0.202 by €0.028.
Is Koninklijke Philips N.V. overvalued?
According to Wall Street analysts Koninklijke Philips N.V.’s price is currently Undervalued.
Does Koninklijke Philips N.V. pay dividends?
Koninklijke Philips N.V. pays a Annually dividend of €0.85 which represents an annual dividend yield of 3.73%. See more information on Koninklijke Philips N.V. dividends here
What is Koninklijke Philips N.V.’s EPS estimate?
Koninklijke Philips N.V.’s EPS estimate is 0.35.
How many shares outstanding does Koninklijke Philips N.V. have?
Koninklijke Philips N.V. has 982,884,770 shares outstanding.
What happened to Koninklijke Philips N.V.’s price movement after its last earnings report?
Koninklijke Philips N.V. reported an EPS of €0.23 in its last earnings report, beating expectations of €0.202. Following the earnings report the stock price went up 2.21%.
Which hedge fund is a major shareholder of Koninklijke Philips N.V.?
Currently, no hedge funds are holding shares in NL:PHIA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Koninklijke Philips N.V.
Koninklijke Philips N.V. operates as a leading global healthcare technology enterprise with a presence across North America and numerous international markets. Its operations are organized into three primary divisions: Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses. Within the Diagnosis & Treatment segment, Philips offers advanced diagnostic imaging technologies, including magnetic resonance (MRI), computed tomography (CT), X-ray systems, and innovative detector-based spectral CT solutions, alongside molecular and hybrid imaging for nuclear medicine. The company also provides integrated interventional systems and comprehensive echography (ultrasound) solutions, crucial for diagnosis, treatment planning, and guidance in areas like cardiology, general imaging, obstetrics/gynecology, and point-of-care settings. This segment is further supported by proprietary software platforms designed to facilitate diagnostics and interventions, as well as enterprise diagnostic informatics products and related services. The Connected Care division focuses on solutions for critical patient management, emergency response, and sleep and respiratory conditions. Additionally, it delivers electronic medical record (EMR) and broader care management platforms. For Personal Health, Philips provides a range of consumer products, encompassing oral hygiene solutions such as electric toothbrushes, brush heads, and interdental cleaning and teeth whitening systems. This segment also includes infant feeding and digital parenting solutions, along with male grooming and beauty devices. Philips actively pursues strategic collaborations to enhance its offerings, notably partnering with Ibex Medical Analytics Ltd. to jointly promote digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide. The company also maintains a strategic partnership agreement with NICO.LAB. Established in 1891 and headquartered in Amsterdam, the Netherlands, the company adopted its current name, Koninklijke Philips N.V., in May 2013, having previously operated as Koninklijke Philips Electronics N.V.
PHIA Stock 12 Month Forecast
Average Price Target
€27.00
▲(6.51% Upside)
Technical Analysis
Options Prices
Currently, No data available
---